Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octreotide vs Loperamide for Chemotherapy-Related Diarrhea in Colorectal Cancer
NCT00003057Phase 3Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Mar 1997
- Primary completion
- May 2000
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of octreotide in diarrhea (3 arms), sponsored by Eastern Cooperative Oncology Group. Primary endpoints: Treatment Failure Rate at 5 days and Safety and Adverse Events at 24 days. Started Mar 1997; status: completed.
02
Drugs
octreotide
03
Conditions
diarrhea
Beyond the preview
Go deeper on NCT00003057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003057.